• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks

    Starpharma's VivaGel® Condom Receives Regulatory Approval in Canada

    Chelsea Pratt
    Sep. 13, 2016 02:07AM PST
    Medical Device Investing

    Starpharma Holdings today announced it had been granted a medical device license for the VivaGel® condom by the Canadian regulatory authority, Health Canada. Starpharma’s marketing partner, Ansell, plans to launch the VivaGel® condom in Canada as soon as possible under the LifeStyles® Dual Protect™ brand.

    MELBOURNE, Australia–(BUSINESS WIRE)–Starpharma Holdings Ltd (ASX: SPL) (OTCQX: SPHRY) today announced it had been granted a medical device license for the VivaGel® condom
    by the Canadian regulatory authority, Health Canada.
    Starpharma’s marketing partner, Ansell (ASX: ANN), plans to launch the VivaGel® condom in Canada as soon as possible under the LifeStyles® Dual Protect™ brand.
    The VivaGel® condom is a world-first product based on
    innovative Australian technology. It is the only condom of its type,
    providing barrier protection and incorporating the proprietary compound,
    astodrimer sodium (SPL7013, VivaGel®) in the condom lubricant.
    Starpharma Chief Executive Officer, Dr Jackie Fairley, said, “The
    approval by Health Canada marks a further key commercial milestone for
    the VivaGel® condom product, and is very significant as the
    first North American approval for the product.”
    Jeyan Heper, Ansell’s President and General Manager, Sexual Wellness
    Global Business Unit said “Ansell’s mission is to provide innovative
    solutions for safety, well-being and peace of mind. We pride ourselves
    on our innovative products and the LifeStyles® Dual Protect™
    condom is a great example of this, combining a high-quality condom with
    Starpharma’s VivaGel®, a patented anti-viral technology.”
    Regulatory reviews continue for the VivaGel® condom in a
    number of other geographic regions with further approvals anticipated in
    the coming months.
    In May 2016, Starpharma and Ansell announced
    that VivaGel® condoms were provided to Australian athletes
    ahead of the Olympics in Rio de Janeiro. The antiviral condoms are also
    available for Australian athletes at the Paralympics.
    About VivaGel®
    VivaGel® has been proven in laboratory
    studies to inactivate up to 99.9% of HIV (human immunodeficiency virus),
    HSV (herpes simplex virus) and HPV (human papillomavirus), which are
    viruses that cause STIs.
    VivaGel® was
    also
    recently
    shown in laboratory studies
    to have potent antiviral activity
    against the Zika virus at levels significantly below the concentration
    in the Dual Protect™ condom. It is now known that Zika virus can be
    sexually transmitted.

    Customers in Canada can pre-order LifeStyles® Dual Protect™
    condoms at www.lifestyles.com/dual-protect,
    as of Wednesday 14 September 2016.

    canadaproduct launchaustralia
    The Conversation (0)

    Go Deeper

    AI Powered
    Medical pills branded with Canadian flag.

    Canadian Pharma Stocks: 5 Biggest Companies

    Doctor looking into a microscope

    5 Small Medical Device Companies

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×